Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) is 7.62% higher on its value in year-to-date trading and has touched a low of $0.43 and a high of $6.18 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The QNRX stock was last observed hovering at around $0.67 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $0.70, the stock is 7.14% and 3.18% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.27 million and changing 4.29% at the moment leaves the stock 4.79% off its SMA200. QNRX registered -85.04% loss for a year compared to 6-month gain of 20.76%. The firm has a 50-day simple moving average (SMA 50) of $0.67874 and a 200-day simple moving average (SMA200) of $0.668345.
The stock witnessed a -14.49% loss in the last 1 month and extending the period to 3 months gives it a 43.68%, and is 25.28% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 16.04% over the week and 16.12% over the month.
Quoin Pharmaceuticals Ltd ADR (QNRX) has around 4 employees, a market worth around $3.54M and $0.00M in sales. Distance from 52-week low is 64.78% and -88.67% from its 52-week high. The company has generated returns on investments over the last 12 months (-160.77%).
The EPS is expected to grow by 78.42% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Quoin Pharmaceuticals Ltd ADR (QNRX) Top Institutional Holders
11.0 institutions hold shares in Quoin Pharmaceuticals Ltd ADR (QNRX), with institutional investors hold 6.03% of the company’s shares. The shares outstanding are 5.05M, and float is at 1.12M with Short Float at 15.08%. Institutions hold 5.89% of the Float.
Quoin Pharmaceuticals Ltd ADR (QNRX) Insider Activity
The most recent transaction is an insider purchase by Carter Denise P., the company’s Chief Operating Officer. SEC filings show that Carter Denise P. bought 555,556 shares of the company’s common stock on Dec 23 ’24 at a price of $0.45 per share for a total of $0.25 million. Following the purchase, the insider now owns 0.6 million shares.
Quoin Pharmaceuticals Ltd ADR disclosed in a document filed with the SEC on Dec 23 ’24 that Myers Michael (Chief Executive Officer) bought a total of 555,556 shares of the company’s common stock. The trade occurred on Dec 23 ’24 and was made at $0.45 per share for $0.25 million. Following the transaction, the insider now directly holds 0.6 million shares of the QNRX stock.
Still, SEC filings show that on Dec 23 ’24, Dunn Gordon (Chief Financial Officer) acquired 122,221 shares at an average price of $0.45 for $54999.0. The insider now directly holds 151,077 shares of Quoin Pharmaceuticals Ltd ADR (QNRX).
